Dublin, Feb. 07, 2019 (GLOBE NEWSWIRE) -- The "Genetic Testing - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.
Global Genetic Testing market accounted for $7749.00 million in 2017 and is expected to reach $25948.46 million by 2026 growing at a CAGR of 14.37% during the forecast period.
Factors such as rise in the incidence of genetic diseases and increase in the prevalence of cancer and cardiovascular diseases are fuelling the market growth. Moreover, demand in the benefits offered by genetic testing (such as specificity and early identification) is one of the major opportunities to boost the market during the forecast period. However, inaccuracies in results and reimbursement issues are restricting the growth of the market.
A genetic test is used to determine the DNA sequence of a certain region of the human genome. This region might be a whole gene or a share of a gene, or other areas thought to regulate genes. The test will look for certain changes in the sequence that is known to have consequences on the function of a gene. Mostly genetic tests are performed on a DNA sample, because every tissue in the body is composed of cells that contain DNA.
By type, predictive & pre-symptomatic testing segment acquired significant growth due to increase in awareness about diseases such as cancer and early detection of diseases. Based on end user, hospital based laboratories segment is owing to user convenience and increasing number of hospitals are a few factors projected to propel the hospital-based laboratories segment during the forecast period.
On the basis of geography, North America is considered as the fastest growing market and the factors favouring the growth of this region are developed infrastructure, increase in health care investments, and robust R&D activities in these countries.
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements.
Key Topics Covered:
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.5 Research Sources
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Genetic Testing Market, By Technology
5.1 Introduction
5.2 Biochemical Testing
5.3 Cytogenetic testing
6 Global Genetic Testing Market, By Disease
6.1 Introduction
6.2 Alzheimer Disease
6.3 Cystic Fibrosis
6.4 Huntington Disease
6.5 Duchenne Muscular Dystrophy
6.6 Sickle Cell Anemia
6.7 Cancer Disease
6.8 Thalassemia
6.9 Special Diseases
6.10 Other Diseases
7 Global Genetic Testing Market, By Type
7.1 Introduction
7.2 Predictive & Pre-symptomatic Testing
7.3 Carrier Testing
7.4 Nutrigenomic Testing
7.5 Forensic Testing
7.6 Newborn and Prenatal Testing
7.6.1 Preimplantation Genetic Diagnosis
7.6.2 Diagnostic Techniques
7.6.2.1 Fluorescence in situ hybridization (FISH)
7.6.2.2 Polymerase chain reaction (PCR)
7.6.2.3 Comparative genomic hybridization (CGH)
7.6.3 Screening Methods
7.6.3.1 Maternal serum screening (MSS)
7.6.3.2 Noninvasive prenatal testing (NIPT)
7.7 Molecular Genetic Test/ DNA Test
7.7.1 Direct Sequencing
7.7.2 DNA Microarray Analysis
7.7.3 Chromosomal Genetic Test
7.7.4 Other Molecular Genetic Test/ DNA Tests
7.8 Tandem Mass Spectrometry
7.9 High-performance liquid chromatography
7.10 Gas Chromatography/ Mass Spectrometry
7.11 Other Types
8 Global Genetic Testing Market, By Testing Sample
8.1 Introduction
8.2 Saliva
8.3 Hair
8.4 Blood
8.5 Tumors
8.6 Other Testing Samples
9 Global Genetic Testing Market, By Application
9.1 Introduction
9.2 Cancer Genetic Testing
9.3 Prescribed Genetic Testing
9.4 Pharmacogenomics Genetic Testing
9.5 Predisposition Cancer Genetic Testing
9.6 Direct to consumer (DTC) Genetic Testing
9.7 Neurogenetic Disorder Testing
9.8 Muscular Dystrophies
9.9 Other Applications
10 Global Genetic Testing Market, By End User
10.1 Introduction
10.2 Blood Bank
10.3 Hospitals
10.4 Nursing Homes
10.5 Laboratories
10.6 Specialty clinics
10.7 Other End Users
11 Global Genetic Testing Market, By Geography
11.1 Introduction
11.2 North America
11.3 Europe
11.4 Asia Pacific
11.5 South America
11.6 Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 Illumina Inc
13.2 Abbott Laboratories
13.3 BGI Tech
13.4 Thermo Fisher Sceintific
13.5 Luminex Corporation
13.6 Cepheid
13.7 Qiagen N.V
13.8 Blueprint Genetic
13.9 Pacific Biosciences of California Inc
13.10 Affymetrix
13.11 Bio-Rad Laboratories
13.12 Celera Group
13.13 AutoGenomics Inc.
13.14 Roche Diagnostics Limited
13.15 Molecular Inc.
13.16 Genomictre Inc
13.17 HTG Molecular Diagnostics Inc
13.18 Oxford Biodynamics Ltd
13.19 Roche Holding AG
13.20 National Center for Biotechnology Information
For more information about this report visit https://www.researchandmarkets.com/research/pszj8n/global_genetic?w=12
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.